Skip to content
2000
Volume 24, Issue 2
  • ISSN: 1570-159X
  • E-ISSN: 1875-6190

Abstract

Post-traumatic stress disorder (PTSD) is a chronic and multifactorial psychiatric condition that is often underdiagnosed, particularly when associated with chronic diseases (CDs). These conditions arise from complex interactions among psychosocial, socioeconomic, epigenetic, immune, metabolic, and neurobiological factors. Current treatment options for PTSD and CDs, whether isolated or comorbid, remain suboptimal. Addressing the bidirectional relationship between PTSD and CDs is a pressing global public health challenge, necessitating a deeper understanding of the underlying molecular mechanisms. This review examines the interplay of stress-response and neurochemical factors in PTSD and CDs, highlighting how maladaptive stress responses to trauma can disrupt neurochemical pathways, contributing to the development of CDs, and . Despite this, a significant gap exists in the number of model studies that adequately mimic the comorbid symptoms of PTSD and CDs, hindering progress in elucidating shared cellular and molecular pathways. This limitation restricts therapeutic advancements. Therefore, a comprehensive understanding of the neurobiological dysfunctions in the brain and their crosstalk with the immune, cardiovascular, and endocrine systems is critical. Such insights will pave the way for individualized treatment strategies tailored to the unique profiles of patients with PTSD associated with CDs.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cn/10.2174/011570159X392154250730072830
2025-08-21
2026-02-24

  • From This Site

    /content/journals/cn/10.2174/011570159X392154250730072830
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. IzquierdoI. FuriniC.R.G. MyskiwJ.C. Fear memory.Physiol. Rev.201696269575010.1152/physrev.00018.2015 26983799
     [Google Scholar]
  2. JanniniT.B. LongoL. RossiR. NioluC. SiracusanoA. Di LorenzoG. Complex post-traumatic stress disorder (cPTSD) and suicide risk: A multigroup mediation analysis exploring the role of post-traumatic symptomatology on hopelessness.J. Psychiatr. Res.202316516516910.1016/j.jpsychires.2023.07.032 37506411
     [Google Scholar]
  3. SerpeloniF. NarrogJ.A. PicklerB. AvanciJ.Q. AssisS.G.D. KoebachA. Narrative exposure therapy for the treatment of post-traumatic stress disorder with people who have experienced domestic and community violence: Study of a series of cases in two health centers in Rio de Janeiro, Brazil.Ciênc Saúde Coletiva2023281619163010.1590/1413‑81232023286.16532022en
     [Google Scholar]
  4. MarazzitiD. CarmassiC. CappellatoG. ChiarantiniI. MassoniL. MucciF. AroneA. VioliM. PalermoS. De IorioG. Dell’OssoL. Novel pharmacological targets of post-traumatic stress disorders.Life2023138173110.3390/life13081731 37629588
     [Google Scholar]
  5. LunkenheimerF. GaratvaP. SteublL. BaumeisterH. Prevalence and incidence of post-traumatic stress disorder and symptoms in people with chronic somatic diseases: A systematic review and meta-analysis.Front. Psychiatry202314110714410.3389/fpsyt.2023.1107144 36741119
     [Google Scholar]
  6. KmitaH. PinnaG. LushchakV.I. Potential oxidative stress related targets of mitochondria-focused therapy of PTSD.Front. Physiol.202314126657510.3389/fphys.2023.1266575 38028782
     [Google Scholar]
  7. Dell’OsteV. FantasiaS. GravinaD. PalegoL. BettiL. Dell’OssoL. GiannacciniG. CarmassiC. Metabolic and inflammatory response in post-traumatic stress disorder (PTSD): A systematic review on peripheral neuroimmune biomarkers.Int. J. Environ. Res. Public Health2023204293710.3390/ijerph20042937 36833633
     [Google Scholar]
  8. ChakrabartiS. BisagliaM. Oxidative stress and neuroinflammation in Parkinson’s disease: The role of dopamine oxidation products.Antioxidants202312495510.3390/antiox12040955 37107329
     [Google Scholar]
  9. PrietoS. NolanK.E. MoodyJ.N. HayesS.M. HayesJ.P. Posttraumatic stress symptom severity predicts cognitive decline beyond the effect of Alzheimer’s disease biomarkers in Veterans.Transl. Psychiatry202313110210.1038/s41398‑023‑02354‑0 36990983
     [Google Scholar]
  10. RibeiroA.C.A.F. BatistaT.H. FerrariM.S. Giusti-PaivaA. VilelaF.C. The accentuation in post-traumatic stress disorder-like symptoms induced by diabetes in rats is not associated with a further increase in astrocyte activation in the hippocampus.Neurosci. Lett.202176213617410.1016/j.neulet.2021.136174 34400287
     [Google Scholar]
  11. BrownL.C. MurphyA.R. LalondeC.S. SubhedarP.D. MillerA.H. StevensJ.S. Posttraumatic stress disorder and breast cancer: Risk factors and the role of inflammation and endocrine function.Cancer2020126143181319110.1002/cncr.32934 32374431
     [Google Scholar]
  12. YangJ. ZhangS. WuQ. ChenP. DaiY. LongJ. WuY. LinY. T cell-mediated skin-brain axis: Bridging the gap between psoriasis and psychiatric comorbidities.J. Autoimmun.202414410317610.1016/j.jaut.2024.103176 38364575
     [Google Scholar]
  13. ZepfS. ZepfF.D. Trauma and traumatic neurosis: Freud’s concepts revisited.Int. J. Psychoanal.200889233135310.1111/j.1745‑8315.2008.00038.x 18405287
     [Google Scholar]
  14. AverillL.A. JiangL. PurohitP. CoppoliA. AverillC.L. RoscoeJ. KelmendiB. De FeyterH.M. de GraafR.A. GueorguievaR. SanacoraG. KrystalJ.H. RothmanD.L. MasonG.F. AbdallahC.G. Prefrontal glutamate neurotransmission in PTSD: A novel approach to estimate synaptic strength in vivo in humans.Chronic Stress202262470547022109273410.1177/24705470221092734 35434443
     [Google Scholar]
  15. SantelloM. VolterraA. TNFα in synaptic function: Switching gears.Trends Neurosci.2012351063864710.1016/j.tins.2012.06.001 22749718
     [Google Scholar]
  16. HaroonE. MillerA.H. SanacoraG. Inflammation, glutamate, and glia: A trio of trouble in mood disorders.Neuropsychopharmacology201742119321510.1038/npp.2016.199 27629368
     [Google Scholar]
  17. PinnaG. KmitaH. LushchakV.I. Editorial: Role of mitochondria in post-traumatic stress disorder (PTSD).Front. Physiol.202314134120410.3389/fphys.2023.1341204 38162825
     [Google Scholar]
  18. HeM. WeiJ.X. MaoM. ZhaoG.Y. TangJ.J. FengS. LuX.M. WangY.T. Synaptic plasticity in PTSD and associated comorbidities: the function and mechanism for diagnostics and therapy.Curr. Pharm. Des.201924344051405910.2174/1381612824666181120094749 30457048
     [Google Scholar]
  19. GoliaM.T. PogginiS. AlboniS. GarofaloS. Ciano AlbaneseN. ViglioneA. Ajmone-CatM.A. St-PierreA. BrunelloN. LimatolaC. BranchiI. MaggiL. Interplay between inflammation and neural plasticity: Both immune activation and suppression impair LTP and BDNF expression.Brain Behav. Immun.20198148449410.1016/j.bbi.2019.07.003 31279682
     [Google Scholar]
  20. BauerM.E. WieckA. LopesR.P. TeixeiraA.L. Grassi-OliveiraR. Interplay between neuroimmunoendocrine systems during post-traumatic stress disorder: A minireview.Neuroimmunomodulation201017319219510.1159/000258721 20134200
     [Google Scholar]
  21. GodoyL.D. RossignoliM.T. Delfino-PereiraP. Garcia-CairascoN. de Lima UmeokaE.H. A comprehensive overview on stress neurobiology: Basic concepts and clinical implications.Front. Behav. Neurosci.20181212710.3389/fnbeh.2018.00127 30034327
     [Google Scholar]
  22. Raise-AbdullahiP. MeamarM. VafaeiA.A. AlizadehM. DadkhahM. ShafiaS. Ghalandari-ShamamiM. NaderianR. SamaeiA.S. Rashidy-PourA. Hypothalamus and post-traumatic stress disorder: A review.Brain Sci.2023137101010.3390/brainsci13071010 37508942
     [Google Scholar]
  23. VedharaK. CoxN.K.M. WilcockG.K. PerksP. HuntM. AndersonS. LightmanS.L. ShanksN.M. Chronic stress in elderly carers of dementia patients and antibody response to influenza vaccination.Lancet1999353915362763110.1016/S0140‑6736(98)06098‑X 10030328
     [Google Scholar]
  24. SchoorlemmerR.M.M. PeetersG.M.E.E. Van SchoorN.M. LipsP. Relationships between cortisol level, mortality and chronic diseases in older persons.Clin. Endocrinol.200971677978610.1111/j.1365‑2265.2009.03552.x 19226268
     [Google Scholar]
  25. OgłodekE.A. Changes in the serum concentration levels of serotonin, tryptophan and cortisol among stress-resilient and stress-susceptible individuals after experiencing traumatic stress.Int. J. Environ. Res. Public Health202219241651710.3390/ijerph192416517 36554398
     [Google Scholar]
  26. PanW. Blood-brain barrier interfaces: from ontogeny to artificial barriers.Q. Rev. Biol.200681423
     [Google Scholar]
  27. CohenS. Janicki-DevertsD. DoyleW.J. MillerG.E. FrankE. RabinB.S. TurnerR.B. Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk.Proc. Natl. Acad. Sci. USA2012109165995599910.1073/pnas.1118355109 22474371
     [Google Scholar]
  28. CernackovaA. DurackovaZ. TrebatickaJ. MravecB. Neuroinflammation and depressive disorder: The role of the hypothalamus.J. Clin. Neurosci.20207551010.1016/j.jocn.2020.03.005 32217047
     [Google Scholar]
  29. MurphyF. NasaA. CullinaneD. RaajakesaryK. GazzazA. SooknarineV. HainesM. RomanE. KellyL. O’NeillA. CannonM. RoddyD.W. Childhood trauma, the HPA axis and psychiatric illnesses: A targeted literature synthesis.Front. Psychiatry20221374837210.3389/fpsyt.2022.748372 35599780
     [Google Scholar]
  30. PanW. StoneK.P. HsuchouH. MandaV.K. ZhangY. KastinA.J. Cytokine signaling modulates blood-brain barrier function.Curr. Pharm. Des.201117333729374010.2174/138161211798220918 21834767
     [Google Scholar]
  31. LindqvistD. DhabharF.S. MellonS.H. YehudaR. GrenonS.M. FloryJ.D. BiererL.M. Abu-AmaraD. CoyM. MakotkineI. ReusV.I. BersaniF.S. MarmarC.R. WolkowitzO.M. Increased pro-inflammatory milieu in combat related PTSD – A new cohort replication study.Brain Behav. Immun.20175926026410.1016/j.bbi.2016.09.012 27638184
     [Google Scholar]
  32. WaheedA. DaltonB. WesemannU. IbrahimM.A.A. HimmerichH. A systematic review of interleukin-1β in post-traumatic stress disorder: Evidence from human and animal studies.J. Interferon Cytokine Res.201838111110.1089/jir.2017.0088 29328883
     [Google Scholar]
  33. YarlagaddaA. AlfsonE. ClaytonA.H. The blood brain barrier and the role of cytokines in neuropsychiatry.Psychiatry20096111822 20049146
     [Google Scholar]
  34. HuangX. HussainB. ChangJ. Peripheral inflammation and blood-brain barrier disruption: Effects and mechanisms.CNS Neurosci. Ther.2021271364710.1111/cns.13569 33381913
     [Google Scholar]
  35. WilsonE.H. WeningerW. HunterC.A. Trafficking of immune cells in the central nervous system.J. Clin. Invest.201012051368137910.1172/JCI41911 20440079
     [Google Scholar]
  36. BanksW.A. EricksonM.A. The blood–brain barrier and immune function and dysfunction.Neurobiol. Dis.2010371263210.1016/j.nbd.2009.07.031 19664708
     [Google Scholar]
  37. PanX. KamingaA.C. Wu WenS. LiuA. Chemokines in post-traumatic stress disorder: A network meta-analysis.Brain Behav. Immun.20219211512610.1016/j.bbi.2020.11.033 33242653
     [Google Scholar]
  38. QinL. WuX. BlockM.L. LiuY. BreeseG.R. HongJ.S. KnappD.J. CrewsF.T. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration.Glia200755545346210.1002/glia.20467 17203472
     [Google Scholar]
  39. KellermannN.P. Epigenetic transmission of Holocaust trauma: Can nightmares be inherited?Isr. J. Psychiatry Relat. Sci.20135013339 24029109
     [Google Scholar]
  40. ZannasA.S. WiechmannT. GassenN.C. BinderE.B. Gene-stress-epigenetic regulation of FKBP5: Clinical and translational implications.Neuropsychopharmacology201641126127410.1038/npp.2015.235 26250598
     [Google Scholar]
  41. LiH. SuP. LaiT.K.Y. JiangA. LiuJ. ZhaiD. CampbellC.T.G. LeeF.H.F. YongW. PasrichaS. LiS. WongA.H.C. ResslerK.J. LiuF. The glucocorticoid receptor-FKBP51 complex contributes to fear conditioning and posttraumatic stress disorder.J. Clin. Invest.2020130287788910.1172/JCI130363 31929189
     [Google Scholar]
  42. JiangA. ZhouC. SamsomJ. YanS. YuD.Z. JiaZ. WongA.H.C. LiuF. The GR-FKBP51 interaction modulates fear memory but not spatial or recognition memory.Prog. Neuropsychopharmacol. Biol. Psychiatry202211911060410.1016/j.pnpbp.2022.110604 35839967
     [Google Scholar]
  43. GeuzeE. van BerckelB.N.M. LammertsmaA.A. BoellaardR. de KloetC.S. VermettenE. WestenbergH.G.M. Reduced GABAA benzodiazepine receptor binding in veterans with post-traumatic stress disorder.Mol. Psychiatry,20081317483310.1038/sj.mp.4002054 17667960
     [Google Scholar]
  44. HuangJ. XuF. YangL. TuolihongL. WangX. DuZ. ZhangY. YinX. LiY. LuK. WangW. Involvement of the GABAergic system in PTSD and its therapeutic significance.Front. Mol. Neurosci.202316105228810.3389/fnmol.2023.1052288 36818657
     [Google Scholar]
  45. GanY.L. WangC.Y. HeR.H. HsuP.C. YehH.H. HsiehT.H. LinH.C. ChengM.Y. JengC.J. HuangM.C. LeeY.H. FKBP51 mediates resilience to inflammation-induced anxiety through regulation of glutamic acid decarboxylase 65 expression in mouse hippocampus.J. Neuroinflammation202219115210.1186/s12974‑022‑02517‑8 35705957
     [Google Scholar]
  46. CodagnoneM.G. KaraN. RatsikaA. LevoneB.R. van de WouwM. TanL.A. CunninghamJ.I. SanchezC. CryanJ.F. O’LearyO.F. Inhibition of FKBP51 induces stress resilience and alters hippocampal neurogenesis.Mol. Psychiatry202227124928493810.1038/s41380‑022‑01755‑9 36104438
     [Google Scholar]
  47. BinderE.B. BradleyR.G. LiuW. EpsteinM.P. DeveauT.C. MercerK.B. TangY. GillespieC.F. HeimC.M. NemeroffC.B. SchwartzA.C. CubellsJ.F. ResslerK.J. Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults.JAMA2008299111291130510.1001/jama.299.11.1291 18349090
     [Google Scholar]
  48. HawnS.E. SheerinC.M. LindM.J. HicksT.A. MarracciniM.E. BountressK. BacanuS.A. NugentN.R. AmstadterA.B. GxE effects of FKBP5 and traumatic life events on PTSD: A meta-analysis.J. Affect. Disord.201924345546210.1016/j.jad.2018.09.058 30273884
     [Google Scholar]
  49. XieP. KranzlerH.R. PolingJ. SteinM.B. AntonR.F. FarrerL.A. GelernterJ. Interaction of FKBP5 with childhood adversity on risk for post-traumatic stress disorder.Neuropsychopharmacology20103581684169210.1038/npp.2010.37 20393453
     [Google Scholar]
  50. Galatzer-LevyI.R. AnderoR. SawamuraT. JovanovicT. PapiniS. ResslerK.J. NorrholmS.D. A cross species study of heterogeneity in fear extinction learning in relation to FKBP5 variation and expression: Implications for the acute treatment of posttraumatic stress disorder.Neuropharmacology201711618819510.1016/j.neuropharm.2016.12.023 28025095
     [Google Scholar]
  51. ZoladzP.R. DaileyA.M. NagleH.E. FielyM.K. MosleyB.E. BrownC.M. DuffyT.J. ScharfA.R. EarleyM.B. RorabaughB.R. FKBP5 polymorphisms influence pre‐learning stress‐induced alterations of learning and memory.Eur. J. Neurosci.201745564865910.1111/ejn.13514 28002634
     [Google Scholar]
  52. ZannasA.S. BinderE.B. Gene-environment interactions at the FKBP5 locus: Sensitive periods, mechanisms and pleiotropism.Genes Brain Behav.2014131253710.1111/gbb.12104 24219237
     [Google Scholar]
  53. BortsovA.V. SmithJ.E. DiatchenkoL. SowardA.C. UlirschJ.C. RossiC. SworR.A. HaudaW.E. PeakD.A. JonesJ.S. HolbrookD. RathlevN.K. FoleyK.A. LeeD.C. ColletteR. DomeierR.M. HendryP.L. McLeanS.A. Polymorphisms in the glucocorticoid receptor co-chaperone FKBP5 predict persistent musculoskeletal pain after traumatic stress exposure.Pain201315481419142610.1016/j.pain.2013.04.037 23707272
     [Google Scholar]
  54. JadhakhanF. EvansD. FallaD. Role of post-trauma stress symptoms in the development of chronic musculoskeletal pain and disability: A protocol for a systematic review.BMJ Open20211112e05838610.1136/bmjopen‑2021‑058386 34853117
     [Google Scholar]
  55. KlineN.K. BerkeD.S. RhodesC.A. SteenkampM.M. LitzB.T. Self-blame and PTSD following sexual assault: A longitudinal analysis.J. Interpers. Violence2021365-6NP3153NP316810.1177/0886260518770652 29683081
     [Google Scholar]
  56. ClausenA.N. FranciscoA.J. ThelenJ. BruceJ. MartinL.E. McDowdJ. SimmonsW.K. AupperleR.L. PTSD and cognitive symptoms relate to inhibition-related prefrontal activation and functional connectivity.Depress. Anxiety201734542743610.1002/da.22613 28370684
     [Google Scholar]
  57. BlackburnT.P. Depressive disorders: Treatment failures and poor prognosis over the last 50 years.Pharmacol. Res. Perspect.201973e0047210.1002/prp2.472 31065377
     [Google Scholar]
  58. AdayJ.S. MitzkovitzC.M. BloeschE.K. DavoliC.C. DavisA.K. Long-term effects of psychedelic drugs: A systematic review.Neurosci. Biobehav. Rev.202011317918910.1016/j.neubiorev.2020.03.017 32194129
     [Google Scholar]
  59. CarbonaroT.M. BradstreetM.P. BarrettF.S. MacLeanK.A. JesseR. JohnsonM.W. GriffithsR.R. Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences.J. Psychopharmacol.201630121268127810.1177/0269881116662634 27578767
     [Google Scholar]
  60. Palhano-FontesF. BarretoD. OniasH. AndradeK.C. NovaesM.M. PessoaJ.A. Mota-RolimS.A. OsórioF.L. SanchesR. dos SantosR.G. TófoliL.F. de Oliveira SilveiraG. YonamineM. RibaJ. SantosF.R. Silva-JuniorA.A. AlchieriJ.C. Galvão-CoelhoN.L. Lobão-SoaresB. HallakJ.E.C. ArcoverdeE. Maia-de-OliveiraJ.P. AraújoD.B. Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: A randomized placebo-controlled trial.Psychol. Med.201949465566310.1017/S0033291718001356 29903051
     [Google Scholar]
  61. Galvão-CoelhoN.L. de Menezes GalvãoA.C. de AlmeidaR.N. Palhano-FontesF. Campos BragaI. Lobão SoaresB. Maia-de-OliveiraJ.P. PerkinsD. SarrisJ. de AraujoD.B. Changes in inflammatory biomarkers are related to the antidepressant effects of Ayahuasca.J. Psychopharmacol.202034101125113310.1177/0269881120936486 32648790
     [Google Scholar]
  62. dos SantosR.G. OsórioF.L. RochaJ.M. RossiG.N. BousoJ.C. RodriguesL.S. de Oliveira SilveiraG. YonamineM. HallakJ.E.C. Ayahuasca improves self-perception of speech performance in subjects with social anxiety disorder: A pilot, proof-of-concept, randomized, placebo-controlled trial.J. Clin. Psychopharmacol.202141554055010.1097/JCP.0000000000001428 34166299
     [Google Scholar]
  63. WeissB. Dinh-WilliamsL.A.L. BellerN. RaughI.M. StraussG.P. CampbellW.K. Ayahuasca in the treatment of posttraumatic stress disorder: Mixed-methods case series evaluation in military combat veterans.Psychol. Trauma202416S718S72210.1037/tra0001625 38059941
     [Google Scholar]
  64. MitchellJ.M. Ot’aloraG. M.; van der Kolk, B.; Shannon, S.; Bogenschutz, M.; Gelfand, Y.; Paleos, C.; Nicholas, C.R.; Quevedo, S.; Balliett, B.; Hamilton, S.; Mithoefer, M.; Kleiman, S.; Parker-Guilbert, K.; Tzarfaty, K.; Harrison, C.; de Boer, A.; Doblin, R.; Yazar-Klosinski, B.; Harrison, C.; Yazar-Klosinski, B.; Garas, W.; May, D.; Marta, C.; Walker, S.; Nielson, E.; Wells, G.; Brown, R.; Amiaz, R.; Wallach, Y.; Worthy, R.; Lilienstein, A.; Emerson, A. MDMA-assisted therapy for moderate to severe PTSD: A randomized, placebo-controlled phase 3 trial.Nat. Med.202329102473248010.1038/s41591‑023‑02565‑4 37709999
     [Google Scholar]
  65. FeducciaA.A. JeromeL. Yazar-KlosinskiB. EmersonA. MithoeferM.C. DoblinR. Breakthrough for trauma treatment: Safety and efficacy of MDMA-assisted psychotherapy compared to paroxetine and sertraline.Front. Psychiatry20191065010.3389/fpsyt.2019.00650 31572236
     [Google Scholar]
  66. BolsoniL.M. CrippaJ.A.S. HallakJ.E.C. GuimarãesF.S. ZuardiA.W. Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder.Psychopharmacology202223951499150710.1007/s00213‑021‑06043‑y 35029706
     [Google Scholar]
  67. TelchM.J. FischerC.M. ZaizarE.D. RubinM. PapiniS. Use of Cannabidiol (CBD) oil in the treatment of PTSD: Study design and rationale for a placebo-controlled randomized clinical trial.Contemp. Clin. Trials202212210693310.1016/j.cct.2022.106933 36154908
     [Google Scholar]
  68. JakovljevicM. JakabM. GerdthamU. McDaidD. OguraS. VaravikovaE. MerrickJ. AdanyR. OkunadeA. GetzenT.E. Comparative financing analysis and political economy of noncommunicable diseases.J. Med. Econ.201922872272710.1080/13696998.2019.1600523 30913928
     [Google Scholar]
  69. MackenbachJ.P. The rise and fall of diseases: Reflections on the history of population health in Europe since ca. 1700.Eur. J. Epidemiol.202136121199120510.1007/s10654‑021‑00719‑7 33611677
     [Google Scholar]
  70. ShawA.C. GoldsteinD.R. MontgomeryR.R. Age-dependent dysregulation of innate immunity.Nat. Rev. Immunol.2013131287588710.1038/nri3547 24157572
     [Google Scholar]
  71. MillerM.W. SadehN. Traumatic stress, oxidative stress and post-traumatic stress disorder: Neurodegeneration and the accelerated-aging hypothesis.Mol. Psychiatry201419111156116210.1038/mp.2014.111 25245500
     [Google Scholar]
  72. SmithK.L. KassemM.S. ClarkeD.J. KuligowskiM.P. Bedoya-PérezM.A. ToddS.M. LagopoulosJ. BennettM.R. ArnoldJ.C. Microglial cell hyper-ramification and neuronal dendritic spine loss in the hippocampus and medial prefrontal cortex in a mouse model of PTSD.Brain Behav. Immun.20198088989910.1016/j.bbi.2019.05.042 31158497
     [Google Scholar]
  73. KinneyJ.W. BemillerS.M. MurtishawA.S. LeisgangA.M. SalazarA.M. LambB.T. Inflammation as a central mechanism in Alzheimer’s disease.Alzheimers Dement.20184157559010.1016/j.trci.2018.06.014 30406177
     [Google Scholar]
  74. HampelH. HardyJ. BlennowK. ChenC. PerryG. KimS.H. VillemagneV.L. AisenP. VendruscoloM. IwatsuboT. MastersC.L. ChoM. LannfeltL. CummingsJ.L. VergalloA. The amyloid-β pathway in Alzheimer’s disease.Mol. Psychiatry202126105481550310.1038/s41380‑021‑01249‑0 34456336
     [Google Scholar]
  75. WhiteS. MauerR. LangeC. KlimeckiO. HuijbersW. WirthM. The effect of plasma cortisol on hippocampal atrophy and clinical progression in mild cognitive impairment.Alzheimers Dement.2023153e1246310.1002/dad2.12463 37583892
     [Google Scholar]
  76. P, S.; Vellapandian, C. Hypothalamic-pituitary-adrenal (HPA) axis: Unveiling the potential mechanisms involved in stress-induced Alzheimer’s disease and depression.Cureus2024168e6759510.7759/cureus.67595 39310640
     [Google Scholar]
  77. WangA. WeiZ. YuanH. ZhuY. PengY. GaoZ. LiuY. ShenJ. XuH. GuanJ. YinS. LiuF. LiX. FKBP5genetic variants are associated with respiratory- and sleep-related parameters in Chinese patients with obstructive sleep apnea.Front. Neurosci.202317117088910.3389/fnins.2023.1170889 37274192
     [Google Scholar]
  78. JinwalU.K. KorenJ. BorysovS.I. SchmidA.B. AbisambraJ.F. BlairL.J. JohnsonA.G. JonesJ.R. ShultsC.L. O’LearyJ.C. JinY. BuchnerJ. CoxM.B. DickeyC.A. The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.J. Neurosci.201030259159910.1523/JNEUROSCI.4815‑09.2010 20071522
     [Google Scholar]
  79. AlbuS. RomanowskiC.P.N. Letizia CurziM. JakubcakovaV. FlachskammC. GassenN.C. HartmannJ. SchmidtM.V. SchmidtU. ReinT. HolsboerF. HauschF. Paez-PeredaM. KimuraM. Deficiency of FK 506‐binding protein (FKBP) 51 alters sleep architecture and recovery sleep responses to stress in mice.J. Sleep Res.201423217618510.1111/jsr.12112 24354785
     [Google Scholar]
  80. BailusB.J. ScheelerS.M. SimonsJ. SanchezM.A. TshilengeK.T. Creus-MuncunillJ. NaphadeS. Lopez-RamirezA. ZhangN. Lakshika MadushaniK. MorozS. LoureiroA. SchreiberK.H. HauschF. KennedyB.K. EhrlichM.E. EllerbyL.M. Modulating FKBP5/FKBP51 and autophagy lowers HTT (huntingtin) levels.Autophagy202117124119414010.1080/15548627.2021.1904489 34024231
     [Google Scholar]
  81. WeiX.E. ZhangF.Y. WangK. ZhangQ.X. RongL.Q. Assembly of the FKBP51–PHLPP2–AKT signaling complex in cerebral ischemia/reperfusion injury in rats.Brain Res.20141566606810.1016/j.brainres.2014.04.009 24746496
     [Google Scholar]
  82. MaatoukL. YiC. Carrillo-de SauvageM.A. CompagnionA.C. HunotS. EzanP. HirschE.C. KoulakoffA. PfriegerF.W. TroncheF. LeybaertL. GiaumeC. VyasS. Glucocorticoid receptor in astrocytes regulates midbrain dopamine neurodegeneration through connexin hemichannel activity.Cell Death Differ.201926358059610.1038/s41418‑018‑0150‑3 30006609
     [Google Scholar]
  83. ZhangW. XiaoD. MaoQ. XiaH. Role of neuroinflammation in neurodegeneration development.Signal Transduct. Target. Ther.20238126710.1038/s41392‑023‑01486‑5 37433768
     [Google Scholar]
  84. WerleI. NascimentoL.M.M. dos SantosA.L.A. SoaresL.A. dos SantosR.G. HallakJ.E.C. BertoglioL.J. Ayahuasca‐enhanced extinction of fear behaviour: Role of infralimbic cortex 5‐HT2A and 5‐HT1A receptors.Br. J. Pharmacol.2024181111671168910.1111/bph.16315 38320596
     [Google Scholar]
  85. JiL.L. PengJ.B. FuC.H. CaoD. LiD. TongL. WangZ.Y. Activation of Sigma-1 receptor ameliorates anxiety-like behavior and cognitive impairments in a rat model of post-traumatic stress disorder.Behav. Brain Res.201631140841510.1016/j.bbr.2016.05.056 27275520
     [Google Scholar]
  86. Morales-GarciaJ.A. Calleja-CondeJ. Lopez-MorenoJ.A. Alonso-GilS. Sanz-San CristobalM. RibaJ. Perez-CastilloA. N,N-dimethyltryptamine compound found in the hallucinogenic tea ayahuasca, regulates adult neurogenesis in vitro and in vivo.Transl. Psychiatry202010133110.1038/s41398‑020‑01011‑0 32989216
     [Google Scholar]
  87. WangY.H. SamoylenkoV. TekwaniB.L. KhanI.A. MillerL.S. ChaurasiyaN.D. RahmanM.M. TripathiL.M. KhanS.I. JoshiV.C. WiggerF.T. MuhammadI. Composition, standardization and chemical profiling of Banisteriopsis caapi, a plant for the treatment of neurodegenerative disorders relevant to Parkinson’s disease.J. Ethnopharmacol.2010128366267110.1016/j.jep.2010.02.013 20219660
     [Google Scholar]
  88. SamoylenkoV. RahmanM.M. TekwaniB.L. TripathiL.M. WangY.H. KhanS.I. KhanI.A. MillerL.S. JoshiV.C. MuhammadI. Banisteriopsis caapi, a unique combination of MAO inhibitory and antioxidative constituents for the activities relevant to neurodegenerative disorders and Parkinson’s disease.J. Ethnopharmacol.2010127235736710.1016/j.jep.2009.10.030 19879939
     [Google Scholar]
  89. SchwarzM.J. HoughtonP.J. RoseS. JennerP. LeesA.D. Activities of extract and constituents of Banisteriopsis caapi relevant to parkinsonism.Pharmacol. Biochem. Behav.200375362763310.1016/S0091‑3057(03)00129‑1 12895680
     [Google Scholar]
  90. Calderón-GarcidueñasL. RajkumarR.P. StommelE.W. KuleszaR. MansourY. Rico-VillanuevaA. Flores-VázquezJ.O. Brito-AguilarR. Ramírez-SánchezS. García-AlonsoG. Chávez-FrancoD.A. Luévano-CastroS.C. García-RojasE. Revueltas-FicachiP. Villarreal-RíosR. MukherjeeP.S. Brainstem quadruple aberrant hyperphosphorylated tau, beta-amyloid, alpha-synuclein and TDP-43 pathology, stress and sleep behavior disorders.Int. J. Environ. Res. Public Health20211813668910.3390/ijerph18136689 34206224
     [Google Scholar]
  91. Hernández-DíazY. Genis-MendozaA.D. González-CastroT.B. Tovilla-ZárateC.A. Juárez-RojopI.E. López-NarváezM.L. NicoliniH. Association and genetic expression between genes involved in HPA axis and suicide behavior: A systematic review.Genes20211210160810.3390/genes12101608 34681002
     [Google Scholar]
  92. GebruN.T. GuerguesJ. VerdinaL.A. WohlfahrtJ. WangS. ArmendarizD.S. GrayM. Beaulieu-AbdelahadD. StevensS.M. GulickD. BlairL.J. Fkbp5gene deletion: Circadian rhythm profile and brain proteomics in aged mice.Aging Cell20242312e1431410.1111/acel.14314 39225086
     [Google Scholar]
  93. StechschulteL.A. QiuB. WarrierM. HindsT.D. ZhangM. GuH. XuY. KhuderS.S. RussoL. NajjarS.M. Lecka-CzernikB. YongW. SanchezE.R. FKBP51 null mice are resistant to diet-induced obesity and the PPARγ agonist rosiglitazone.Endocrinology2016157103888390010.1210/en.2015‑1996 27442117
     [Google Scholar]
  94. Criado-MarreroM. GebruN.T. GouldL.A. BlazierD.M. Vidal-AguiarY. SmithT.M. AbdelmaboudS.S. SheltonL.B. WangX. DahrendorffJ. Beaulieu-AbdelahadD. DickeyC.A. BlairL.J. FKBP52 overexpression accelerates hippocampal-dependent memory impairments in a tau transgenic mouse model.NPJ Aging Mech. Dis.202171910.1038/s41514‑021‑00062‑x 33941782
     [Google Scholar]
  95. RibeiroT.O. Bueno-de-CamargoL.M. WaltrickA.P.F. de OliveiraA.R. BrandãoM.L. MunhozC.D. ZanoveliJ.M. Activation of mineralocorticoid receptors facilitate the acquisition of fear memory extinction and impair the generalization of fear memory in diabetic animals.Psychopharmacology2020237252954210.1007/s00213‑019‑05388‑9 31713655
     [Google Scholar]
  96. JelenikT. DilleM. Müller-LühlhoffS. KabraD.G. ZhouZ. BinschC. HartwigS. LehrS. ChadtA. PetersE.M.J. KruseJ. RodenM. Al-HasaniH. CastañedaT.R. FGF21 regulates insulin sensitivity following long-term chronic stress.Mol. Metab.20181612613810.1016/j.molmet.2018.06.012 29980484
     [Google Scholar]
  97. MusumeciG. SciarrettaC. Rodríguez-MorenoA. Al BanchaabouchiM. Negrete-DíazV. CostanziM. BernoV. EgorovA.V. von Bohlen und HalbachO. CestariV. Delgado-GarcíaJ.M. MinichielloL. TrkB modulates fear learning and amygdalar synaptic plasticity by specific docking sites.J. Neurosci.20092932101311014310.1523/JNEUROSCI.1707‑09.2009 19675247
     [Google Scholar]
  98. TaylorK.R. BarronT. HuiA. SpitzerA. YalçinB. IvecA.E. GeraghtyA.C. HartmannG.G. ArztM. GillespieS.M. KimY.S. MalekiJ.S. ZhangH. ShamardaniK. SuM. NiL. DuP.P. WooP.J. Silva-TorresA. VenkateshH.S. MancusiR. PonnuswamiA. MulinyaweS. KeoughM.B. ChauI. Aziz-BoseR. TiroshI. SuvàM.L. MonjeM. Glioma synapses recruit mechanisms of adaptive plasticity.Nature2023623798636637410.1038/s41586‑023‑06678‑1 37914930
     [Google Scholar]
  99. KimM.S. LeeW.S. JinW. TrkB promotes breast cancer metastasis via suppression of Runx3 and keap1 expression.Mol. Cells201639325826510.14348/molcells.2016.2310 26657794
     [Google Scholar]
  100. DarenskayaM.A. KolesnikovaL.I. KolesnikovS.I. Oxidative stress: Pathogenetic role in diabetes mellitus and its complications and therapeutic approaches to correction.Bull. Exp. Biol. Med.2021171217918910.1007/s10517‑021‑05191‑7 34173093
     [Google Scholar]
  101. WellenK.E. HotamisligilG.S. Inflammation, stress, and diabetes.J. Clin. Invest.200511551111111910.1172/JCI25102 15864338
     [Google Scholar]
  102. RorabaughB.R. MabeN.W. SeeleyS.L. StoopsT.S. MucherK.E. NeyC.P. GoodmanC.S. HertensteinB.J. RushA.E. KaslerC.D. SargeantA.M. ZoladzP.R. Myocardial fibrosis, inflammation, and altered cardiac gene expression profiles in rats exposed to a predator-based model of posttraumatic stress disorder.Stress202023212513510.1080/10253890.2019.1641081 31347429
     [Google Scholar]
  103. MattesR.G. EspinosaM.L. OhS.S. AnatrellaE.M. UrteagaE.M. Cannabidiol (CBD) use in type 2 diabetes: A case report.Diabetes Spectr.202134219820110.2337/ds20‑0023 34149261
     [Google Scholar]
  104. de Lima SilvaA.H.B. RadulskiD.R. PereiraG.S. AccoA. ZanoveliJ.M. A single injection of pregabalin induces short- and long-term beneficial effects on fear memory and anxiety-like behavior in rats with experimental type-1 diabetes mellitus.Metab. Brain Dis.20223741095111010.1007/s11011‑022‑00936‑3 35239142
     [Google Scholar]
  105. LuoL. LiL. GuoM. ChenX. LinY. WuD. Genetic variation in NRG 1 gene and risk of post‐traumatic stress disorders in patients with hepatocellular carcinoma.J. Clin. Lab. Anal.2020345e2318710.1002/jcla.23187 31944381
     [Google Scholar]
  106. KimM.S. LeeW.S. JinW. TrkB inhibition of DJ-1 degradation promotes the growth and maintenance of cancer stem cell characteristics in hepatocellular carcinoma.Cell. Mol. Life Sci.2023801030310.1007/s00018‑023‑04960‑z 37749450
     [Google Scholar]
  107. GreenC. R. Corsi-TravaliS. NeumeisterA. The role of BDNFTrkB signaling in the pathogenesis of PTSD. J. Depress Anxiety,20132013(S4), 006.10.4172/2167‑1044.S4‑006 25226879
     [Google Scholar]
  108. IshikawaR.Z. SteereR. ContehN. CramerM.A. RaoV. SprichS. CohenJ.N. Treating PTSD and alcohol use disorder. J. Clin. Psychiatry,202284122ct1463610.4088/JCP.22ct14636 36350590
     [Google Scholar]
  109. BatkiS.L. PenningtonD.L. LasherB. NeylanT.C. MetzlerT. WaldropA. DelucchiK. HerbstE. Topiramate treatment of alcohol use disorder in veterans with posttraumatic stress disorder: A randomized controlled pilot trial.Alcohol. Clin. Exp. Res.20143882169217710.1111/acer.12496 25092377
     [Google Scholar]
/content/journals/cn/10.2174/011570159X392154250730072830
Loading
Unraveling Complex Interactions Mechanisms Linking PTSD and Chronic Diseases
Curr. Neuropharmacol. 24, 163 (2026); https://doi.org/10.2174/011570159X392154250730072830
/content/journals/cn/10.2174/011570159X392154250730072830
/content/journals/cn/10.2174/011570159X392154250730072830
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): chronic diseases; neurochemical factors; neurochemical pathways; Post-traumatic stress disorder; stress-response; treatment

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test